The S&P 500 rose on Tuesday, bolstered by gains in Biogen and upbeat earnings reports that eased concerns over the fallout from the U.S.-China trade war, but the Dow Jones index was pressured by a drop in McDonald's and Travelers.
Volkswagen will start deliveries of its new Golf hatchback in December after shaving an hour off the time needed to build its flagship model, the board member responsible for production at the VW brand said on Tuesday.
Crowdfund Insider | JD Alois | Oct 21,2019 The Cambridge Centre for Alternative Finance (CCAF), part of the Judge School of Business at Cambridge University, has partnered with the World Bank to publish a report on the global regulation of alternative finance and innovative Fintech firms. According to the new report, the regulation of alternative
Lockheed Martin Corp raised its estimate for 2019 earnings on Tuesday as quarterly profit climbed 9.2% amid improved sales of its F-35 fighter jets, sending shares higher even as it forecast a lower cash flow for next year.
Even if you've been happy with your coverage, be aware that insurance carriers make changes from year to year that can affect the drugs they cover and how much they'll cost you.
McDonald's Corp missed Wall Street estimates for profit for the first time in two years on Tuesday as more investment to spruce up U.S. restaurants and speed up delivery weighed on the world's biggest fast food chain, sending its shares down 3%.
Boeing Co is making progress toward getting its 737 MAX aircraft in the air again but the U.S. Federal Aviation Administration (FAA) will need at least several more weeks for review, FAA Administrator Steve Dickson said on Tuesday.
Drug maker Biogen announced it is seeking regulatory approval for its Alzheimer's drug, months after it stopped testing the treatment.
U.S. home sales fell more than expected in September as the market continues to struggle with a dearth of properties for sale, especially for cheaper homes.
SoftBank Group Corp agreed to spend more than $10 billion to take over WeWork, doubling down on an ill-fated investment and paying off its co-founder Adam Neumann to relinquish control, people familiar with the matter said on Tuesday.
Biotech stocks traded higher on Tuesday after Biogen said it would seek approval for its Alzheimer's drug.
U.S. home sales fell more than expected in September as the market continues to struggle with a dearth of properties for sale, especially for cheaper homes.
Stocks on world markets eked out small gains on Tuesday after some upbeat corporate results and talk of progress in China-U.S. trade talks, while sterling weakened as investors awaited further news on Britain's eventual exit from the European Union.
Exxon Mobil Corp on Tuesday was due to face trial in a lawsuit by New York's attorney general accusing it of misleading investors about the risks of climate change regulations to its business.
U.S. companies are responding to the lowest unemployment rate in almost 50 years by increasing their focus on automation in order to maintain healthy margins as labor costs tick higher, a Reuters analysis of corporate earnings transcripts shows.